Blockbuster drugs and one-size-fits-all treatments now share portfolio space with highly targeted therapies for smaller patient populations. This new era is an opportunity for savvy companies to create greater value,
Preparing now for the switch to ISO 13485:2016 For decades, there has been a divide in the medical device regulatory landscape. While the U.S. Food and Drug Administration (FDA) has
The BIO International 2019 conference is only one week away! Here at Argonaut, our team is preparing for a week filled with partnership meetings and exciting talks. This year a
Outsourcing pharmaceutical manufacturing is becoming essential to remain competitive in the industry. The rise of small-batch personalized medicines and “virtual companies” are key drivers to retain flexible, external manufacturing capabilities. With various
Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and
ISPE Aseptice Conference – “Facility of the Future” The always-essential 2019 ISPE Aseptic Conference was held in North Bethesda, MD and we were there to assess the trends, check out
NGS Service Lab Hurdles The sequencing service lab market is hot right now, with over 75,000 genetic tests already available and a predicted clinical sequencing market value of $7.7 billion
Tips on why it’s important to choose the right contract manufacturer location Location, location, location. Important for real estate, but does location matter when choosing a contract manufacturing partner? Absolutely.
Note: This post has been updated – click here to read. In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward a decade, and even
Questions to ask when outsourcing reagent and assay lyophilization Upgrading your reagent or assay with lyophilization offers many advantages, but it can be difficult knowing how to start the process.